CorMedix (CRMD) Amortizatization of Intangibles (2012 - 2025)
CorMedix's (CRMD) quarterly Amortizatization of Intangibles came in at -$3.3 million in Q4 2025, down 8638.37% year-on-year from $38584.0 in Q4 2024, and down 191.51% quarter-over-quarter from $3.6 million in Q3 2025.
CorMedix (CRMD) Amortizatization of Intangibles (2012 - 2025) Analysis & Trends
CorMedix has disclosed Amortizatization of Intangibles across 8 years of filings, most recently posting -$3.3 million for Q4 2025.
- Amortizatization of Intangibles for Q4 2025 came in at -$3.3 million, down 8638.37% year-over-year; the trailing twelve-month figure through Dec 2025 was $396619.0 (down 96.16% YoY), and the FY2025 annual result was $438000.0, up 195.95% from the prior year.
- Amortizatization of Intangibles came in at -$3.3 million for Q4 2025 at CorMedix, down from $3.6 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $10.2 million in Q3 2024 to a low of -$3.3 million in Q4 2025.
- The 5-year median for Amortizatization of Intangibles is $32950.5 (2023), against an average of $554860.2.
- Across the five-year window, Amortizatization of Intangibles jumped 29839.24% in 2024 and sank 8638.37% in 2025, its largest moves.
- CorMedix's Amortizatization of Intangibles stood at $29701.0 in 2021, then rose by 7.27% to $31861.0 in 2022, then grew by 9.34% to $34837.0 in 2023, then rose by 10.76% to $38584.0 in 2024, then tumbled by 8638.37% to -$3.3 million in 2025.
- The last three Amortizatization of Intangibles figures came in at -$3.3 million (Q4 2025), $3.6 million (Q3 2025), and $52000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | CorMedix | 631,378.03 | -154.57 Mn | 107.31 Mn | -3.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.29 Mn |
| Dec 31, 2025 | -3.29 Mn |
| Sep 30, 2025 | 3.60 Mn |
| Sep 30, 2025 | 3.60 Mn |
| Jun 30, 2025 | 52,000.00 |
| Jun 30, 2025 | 52,000.00 |
| Mar 31, 2025 | 39,064.00 |
| Mar 31, 2025 | 39,064.00 |
| Dec 31, 2024 | 38,584.00 |
| Dec 31, 2024 | 38,584.00 |
| Sep 30, 2024 | 10.20 Mn |
| Sep 30, 2024 | 10.20 Mn |
| Jun 30, 2024 | 52,000.00 |
| Jun 30, 2024 | 52,000.00 |
| Mar 31, 2024 | 35,644.00 |
| Mar 31, 2024 | 35,644.00 |
| Dec 31, 2023 | 34,837.00 |
| Dec 31, 2023 | 34,837.00 |
| Sep 30, 2023 | 34,069.00 |
| Sep 30, 2023 | 34,069.00 |